227 related articles for article (PubMed ID: 7873140)
21. Second primary lung malignancy following head and neck squamous cell carcinoma.
Crippen MM; Brady JS; Burke LA; Eloy JA; Baredes S; Park RCW
Laryngoscope; 2019 Apr; 129(4):903-909. PubMed ID: 30565703
[TBL] [Abstract][Full Text] [Related]
22. GTSP1 expression in non-smoker and non-drinker patients with squamous cell carcinoma of the head and neck.
Soares PO; Maluf Cury P; Mendoza López RV; Cernea CR; Fukuyama EE; Livingstone Alves Figueiredo D; Gorgonio da Nobrega F; Curioni OA; Nunes FD; Ajub Moyses R; Bueno Garcia ML;
PLoS One; 2017; 12(8):e0182600. PubMed ID: 28817620
[TBL] [Abstract][Full Text] [Related]
23. A matched control study of treatment outcome in young patients with squamous cell carcinoma of the head and neck.
Verschuur HP; Irish JC; O'Sullivan B; Goh C; Gullane PJ; Pintilie M
Laryngoscope; 1999 Feb; 109(2 Pt 1):249-58. PubMed ID: 10890775
[TBL] [Abstract][Full Text] [Related]
24. Second Primary Head and Neck Cancers After Non-Head and Neck Primary Cancers.
Schlieve T; Heidel RE; Carlson ER
J Oral Maxillofac Surg; 2016 Dec; 74(12):2515-2520. PubMed ID: 27292523
[TBL] [Abstract][Full Text] [Related]
25. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
Olshan AF; Weissler MC; Pei H; Conway K
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
[TBL] [Abstract][Full Text] [Related]
26. Head and neck cancer in nonsmokers: a distinct clinical and molecular entity.
Koch WM; Lango M; Sewell D; Zahurak M; Sidransky D
Laryngoscope; 1999 Oct; 109(10):1544-51. PubMed ID: 10522920
[TBL] [Abstract][Full Text] [Related]
27. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study.
Foulkes WD; Brunet JS; Sieh W; Black MJ; Shenouda G; Narod SA
BMJ; 1996 Sep; 313(7059):716-21. PubMed ID: 8819440
[TBL] [Abstract][Full Text] [Related]
28. Second primary tumours in head and neck cancer.
Herranz González-Botas J; Varela Vázquez P; Vázquez Barro C
Acta Otorrinolaringol Esp; 2016; 67(3):123-9. PubMed ID: 26386656
[TBL] [Abstract][Full Text] [Related]
29. Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy.
Gallo O; Chiarelli I; Boddi V; Bocciolini C; Bruschini L; Porfirio B
Int J Cancer; 1999 Dec; 84(6):573-9. PubMed ID: 10567901
[TBL] [Abstract][Full Text] [Related]
30. Trends in cancer of the head and neck in the elderly in Denmark, 1980-2012.
Johansen J; Grau Eriksen J;
Acta Oncol; 2016; 55 Suppl 1():13-8. PubMed ID: 26760291
[TBL] [Abstract][Full Text] [Related]
31. Analysis of 724 cases of primary head and neck squamous cell carcinoma (HNSCC) with a focus on young patients and p53 immunolocalization.
De Paula AM; Souza LR; Farias LC; Corrêa GT; Fraga CA; Eleutério NB; Silveira AC; Santos FB; Haikal DS; Guimarães AL; Gomez RS
Oral Oncol; 2009 Sep; 45(9):777-82. PubMed ID: 19359212
[TBL] [Abstract][Full Text] [Related]
32. The relation between cancer incidence among relatives and the occurrence of multiple primary carcinomas following head and neck cancer.
Bongers V; Braakhuis BJ; Tobi H; Lubsen H; Snow GB
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):595-8. PubMed ID: 8824360
[TBL] [Abstract][Full Text] [Related]
33. Descriptive epidemiology of head and neck squamous cell carcinoma in Puerto Ricans.
Almodovar J; Pérez SI; Arruza M; Morell CA; Báez A
P R Health Sci J; 1996 Dec; 15(4):251-5. PubMed ID: 9097341
[TBL] [Abstract][Full Text] [Related]
34. Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.
Peltonen JK; Vähäkangas KH; Helppi HM; Bloigu R; Pääkkö P; Turpeenniemi-Hujanen T
Head Neck Oncol; 2011 Apr; 3():20. PubMed ID: 21513535
[TBL] [Abstract][Full Text] [Related]
35. The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites.
Günther K; Foraita R; Friemel J; Günther F; Bullerdiek J; Nimzyk R; Markowski DN; Behrens T; Ahrens W
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):197-205. PubMed ID: 27742669
[TBL] [Abstract][Full Text] [Related]
36. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases.
Tjebbes GW; Leppers vd Straat FG; Tilanus MG; Hordijk GJ; Slootweg PJ
Oral Oncol; 1999 Jul; 35(4):384-9. PubMed ID: 10645403
[TBL] [Abstract][Full Text] [Related]
37. Heavy alcohol drinking downregulates ALDH2 gene expression but heavy smoking up-regulates SOD2 gene expression in head and neck squamous cell carcinoma.
Lee DJ; Lee HM; Kim JH; Park IS; Rho YS
World J Surg Oncol; 2017 Aug; 15(1):163. PubMed ID: 28841898
[TBL] [Abstract][Full Text] [Related]
38. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
[TBL] [Abstract][Full Text] [Related]
39. Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms.
McGarey PO; O'Rourke AK; Owen SR; Shonka DC; Reibel JF; Levine PA; Jameson MJ
JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):40-5. PubMed ID: 26633039
[TBL] [Abstract][Full Text] [Related]
40. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
